Pancreas Neoplasm Clinical Trial
Official title:
Risk Factors for Postoperative Pancreatic Fistula Following Non-traumatic Pancreatic Surgery. Retrospective Observational Study.
| NCT number | NCT05711433 |
| Other study ID # | zagazig 16 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | July 1, 2014 |
| Est. completion date | September 1, 2022 |
| Verified date | February 2023 |
| Source | Zagazig University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational [Patient Registry] |
Postoperative pancreatic fistula is a potentially fatal sequela with substantial morbidity and mortality. A retrospective observational study was conducted in the surgical unit of Zagazig university hospital . Three hundred forty-seven patients were admitted with a clinical diagnosis of pancreatic fistula following both open and laparoscopic approaches for pancreatic benign and malignant tumors.
| Status | Completed |
| Enrollment | 347 |
| Est. completion date | September 1, 2022 |
| Est. primary completion date | July 1, 2019 |
| Accepts healthy volunteers | |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - > 18 years, - both sexes, - respectablee pancreaticoduodenal tumors, or chronic pancreatitis Exclusion Criteria: - <18 years, - Patients who underwent total pancreatectomies, - Patients discovered intraoperatively to be fixed to portal vein or superior mesenteric artery, traumatic pancreatic surgeries, postoperative associated gastric or biliary leak, pancreaticoduodenal cancers infiltrating the colon, stomach or liver. |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Zagazig University |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | incidence of postoperative pancreatic fistula | an amylase level in the fluid collected from the drain on the third postoperative day (POD) that was > three times the serum amylase level | 3.5 years |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05351983 -
Patient-derived Organoids Drug Screen in Pancreatic Cancer
|
N/A | |
| Recruiting |
NCT05155878 -
Prognostic Factors in Periampullary Tumors and Cysts
|
||
| Completed |
NCT03834701 -
Endoscopic Ultrasound-guided RadioFrequency Ablation for the Treatment Pancreatic NeuroEndocrine Neoplasms
|
N/A | |
| Recruiting |
NCT04164602 -
The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly
|
||
| Active, not recruiting |
NCT05095831 -
EUS Shear Wave for Solid Pancreatic Lesions.
|
||
| Recruiting |
NCT04783844 -
Usefulness of 3D Digital Reconstruction in the Imaging Diagnosis of Pancreatic Tumors
|
||
| Recruiting |
NCT03570502 -
Incidence of POPF in the Resection of the Left Pancreas With RFAT
|
||
| Recruiting |
NCT04783831 -
Biodegradable Pancreatic Stents for the Prevention of Postoperative Pancreatic Fistula After Cephalic Pancreaticoduodenectomy
|
||
| Not yet recruiting |
NCT06381882 -
The Role of the Human Microbiome in Patients After Pancreatic Resection.
|
||
| Not yet recruiting |
NCT04336839 -
Portal Vein Resection in Pancreatic Neuroendocrine Tumours
|
||
| Recruiting |
NCT05714111 -
Radiology Registry on Pancreatic Malignancies
|
||
| Recruiting |
NCT05252390 -
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06344507 -
Iconographic Registry of Pancreatobiliary Endoscopy Procedures
|
||
| Recruiting |
NCT04104230 -
Quebec Pancreas Cancer Study
|
||
| Recruiting |
NCT05371223 -
Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases
|
Phase 2 | |
| Recruiting |
NCT04687410 -
Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS-guided Diagnosis of SPLs
|
N/A | |
| Completed |
NCT04724551 -
The Neutrophil-to-Lymphocyte Ratio to Exclude Pancreatic Fistula
|
||
| Withdrawn |
NCT03649035 -
Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma
|
Phase 3 | |
| Recruiting |
NCT04841616 -
Multicentered Prospective Randomized Controlled Trial For Solid Pancreatic Lesions
|
N/A | |
| Completed |
NCT03415126 -
A Study of ASN007 in Patients With Advanced Solid Tumors
|
Phase 1 |